Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hearing Loss | 21 | 2025 | 95 | 8.740 |
Why?
|
| Deafness | 11 | 2023 | 35 | 5.390 |
Why?
|
| Telemedicine | 9 | 2025 | 490 | 3.540 |
Why?
|
| Alaska | 11 | 2025 | 27 | 2.010 |
Why?
|
| Cochlear Implantation | 6 | 2022 | 85 | 1.850 |
Why?
|
| School Health Services | 3 | 2025 | 53 | 1.850 |
Why?
|
| Rural Health Services | 3 | 2025 | 177 | 1.780 |
Why?
|
| Hearing Tests | 3 | 2025 | 28 | 1.760 |
Why?
|
| Hearing Loss, Noise-Induced | 2 | 2023 | 10 | 1.580 |
Why?
|
| Health Services Accessibility | 4 | 2025 | 444 | 1.370 |
Why?
|
| Otitis Media | 3 | 2025 | 36 | 1.310 |
Why?
|
| Community Health Services | 3 | 2019 | 102 | 1.270 |
Why?
|
| Schools | 5 | 2023 | 175 | 1.210 |
Why?
|
| Rural Population | 8 | 2025 | 587 | 1.120 |
Why?
|
| Education | 2 | 2019 | 39 | 1.070 |
Why?
|
| Hearing Loss, Sensorineural | 3 | 2019 | 80 | 1.040 |
Why?
|
| Students | 2 | 2019 | 230 | 1.010 |
Why?
|
| Carnitine O-Palmitoyltransferase | 1 | 2025 | 9 | 0.960 |
Why?
|
| Quality of Life | 8 | 2023 | 893 | 0.920 |
Why?
|
| Mass Screening | 4 | 2022 | 354 | 0.920 |
Why?
|
| Hearing Loss, Bilateral | 2 | 2015 | 8 | 0.890 |
Why?
|
| Hearing | 4 | 2022 | 62 | 0.880 |
Why?
|
| Intelligence | 2 | 2015 | 54 | 0.870 |
Why?
|
| Child | 16 | 2025 | 7194 | 0.860 |
Why?
|
| Humans | 45 | 2025 | 52441 | 0.860 |
Why?
|
| Hemorrhagic Fever, Ebola | 2 | 2022 | 7 | 0.820 |
Why?
|
| Hearing Loss, High-Frequency | 1 | 2023 | 5 | 0.810 |
Why?
|
| Lassa Fever | 2 | 2020 | 2 | 0.800 |
Why?
|
| Child, Preschool | 11 | 2025 | 4046 | 0.780 |
Why?
|
| Referral and Consultation | 5 | 2023 | 288 | 0.770 |
Why?
|
| Randomized Controlled Trials as Topic | 5 | 2025 | 625 | 0.690 |
Why?
|
| Cochlear Implants | 5 | 2022 | 69 | 0.680 |
Why?
|
| Cost-Benefit Analysis | 8 | 2023 | 271 | 0.680 |
Why?
|
| Neurotology | 2 | 2024 | 8 | 0.650 |
Why?
|
| Developing Countries | 5 | 2025 | 64 | 0.640 |
Why?
|
| Prevalence | 6 | 2023 | 1016 | 0.630 |
Why?
|
| Correction of Hearing Impairment | 1 | 2019 | 5 | 0.620 |
Why?
|
| Cholesteatoma | 1 | 2019 | 6 | 0.600 |
Why?
|
| Ear Ossicles | 1 | 2019 | 16 | 0.590 |
Why?
|
| Eustachian Tube | 1 | 2018 | 13 | 0.580 |
Why?
|
| Ear Diseases | 1 | 2018 | 28 | 0.570 |
Why?
|
| Health Care Costs | 1 | 2019 | 176 | 0.560 |
Why?
|
| Research Design | 1 | 2020 | 368 | 0.550 |
Why?
|
| Adolescent | 10 | 2023 | 6713 | 0.540 |
Why?
|
| Malnutrition | 1 | 2018 | 89 | 0.510 |
Why?
|
| Audiometry, Pure-Tone | 3 | 2023 | 53 | 0.510 |
Why?
|
| Auditory Diseases, Central | 1 | 2015 | 1 | 0.480 |
Why?
|
| Auditory Pathways | 1 | 2015 | 7 | 0.480 |
Why?
|
| beta Carotene | 1 | 2015 | 9 | 0.480 |
Why?
|
| Ascorbic Acid | 1 | 2015 | 25 | 0.480 |
Why?
|
| Neurogenesis | 1 | 2015 | 27 | 0.470 |
Why?
|
| Anemia, Iron-Deficiency | 1 | 2015 | 24 | 0.470 |
Why?
|
| Cross-Sectional Studies | 7 | 2022 | 1677 | 0.470 |
Why?
|
| Unemployment | 1 | 2015 | 14 | 0.460 |
Why?
|
| Audiometry | 4 | 2020 | 35 | 0.450 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 1 | 2015 | 58 | 0.450 |
Why?
|
| Hearing Loss, Unilateral | 1 | 2015 | 12 | 0.450 |
Why?
|
| Folic Acid | 1 | 2015 | 137 | 0.450 |
Why?
|
| Primary Health Care | 1 | 2018 | 387 | 0.440 |
Why?
|
| Infant, Premature, Diseases | 1 | 2015 | 93 | 0.440 |
Why?
|
| Poverty | 2 | 2021 | 218 | 0.440 |
Why?
|
| Employment | 1 | 2015 | 94 | 0.430 |
Why?
|
| Vitamin A Deficiency | 1 | 2013 | 6 | 0.420 |
Why?
|
| Ear, Inner | 1 | 2013 | 20 | 0.410 |
Why?
|
| Growth Disorders | 3 | 2018 | 65 | 0.410 |
Why?
|
| Quality-Adjusted Life Years | 5 | 2023 | 67 | 0.390 |
Why?
|
| Diet | 1 | 2015 | 591 | 0.350 |
Why?
|
| Pregnancy Complications | 1 | 2015 | 399 | 0.340 |
Why?
|
| Anti-Retroviral Agents | 1 | 2010 | 19 | 0.330 |
Why?
|
| Treatment Failure | 1 | 2010 | 117 | 0.330 |
Why?
|
| Anti-HIV Agents | 1 | 2010 | 46 | 0.320 |
Why?
|
| Infant | 6 | 2025 | 3709 | 0.310 |
Why?
|
| Female | 15 | 2025 | 28277 | 0.310 |
Why?
|
| Male | 14 | 2025 | 26874 | 0.300 |
Why?
|
| Delivery of Health Care | 2 | 2023 | 317 | 0.300 |
Why?
|
| Multicenter Studies as Topic | 2 | 2019 | 112 | 0.290 |
Why?
|
| Indians, South American | 2 | 2018 | 2 | 0.280 |
Why?
|
| Otolaryngology | 2 | 2025 | 62 | 0.270 |
Why?
|
| Nepal | 2 | 2018 | 12 | 0.260 |
Why?
|
| HIV Infections | 1 | 2010 | 394 | 0.240 |
Why?
|
| Vitamin A | 2 | 2018 | 16 | 0.240 |
Why?
|
| Risk Factors | 3 | 2025 | 3971 | 0.240 |
Why?
|
| Child Development | 2 | 2018 | 208 | 0.240 |
Why?
|
| Hearing Aids | 2 | 2023 | 70 | 0.230 |
Why?
|
| Nutritional Status | 1 | 2025 | 146 | 0.220 |
Why?
|
| Young Adult | 4 | 2020 | 4346 | 0.200 |
Why?
|
| Otoacoustic Emissions, Spontaneous | 1 | 2023 | 6 | 0.200 |
Why?
|
| Prospective Studies | 2 | 2025 | 2433 | 0.200 |
Why?
|
| Crowding | 1 | 2022 | 15 | 0.190 |
Why?
|
| Socioeconomic Factors | 2 | 2015 | 609 | 0.190 |
Why?
|
| Family Characteristics | 1 | 2022 | 59 | 0.190 |
Why?
|
| Dietary Supplements | 2 | 2018 | 470 | 0.180 |
Why?
|
| Water | 1 | 2022 | 87 | 0.180 |
Why?
|
| Biomedical Research | 1 | 2024 | 260 | 0.180 |
Why?
|
| Survivors | 1 | 2022 | 121 | 0.180 |
Why?
|
| World Health Organization | 1 | 2021 | 58 | 0.170 |
Why?
|
| Qualitative Research | 1 | 2023 | 365 | 0.170 |
Why?
|
| United States | 5 | 2024 | 5215 | 0.160 |
Why?
|
| Neglected Diseases | 1 | 2019 | 2 | 0.160 |
Why?
|
| Tropical Climate | 1 | 2019 | 11 | 0.160 |
Why?
|
| Asia | 1 | 2019 | 24 | 0.150 |
Why?
|
| Follow-Up Studies | 2 | 2018 | 2294 | 0.150 |
Why?
|
| Otitis Media, Suppurative | 1 | 2018 | 7 | 0.150 |
Why?
|
| Otitis Media with Effusion | 1 | 2018 | 20 | 0.140 |
Why?
|
| Medical History Taking | 1 | 2018 | 46 | 0.140 |
Why?
|
| Longitudinal Ligaments | 1 | 2018 | 3 | 0.140 |
Why?
|
| Body Height | 1 | 2018 | 65 | 0.140 |
Why?
|
| Preventive Medicine | 1 | 2018 | 22 | 0.140 |
Why?
|
| Middle Ear Ventilation | 1 | 2018 | 20 | 0.140 |
Why?
|
| Thinness | 1 | 2018 | 45 | 0.140 |
Why?
|
| Pneumococcal Vaccines | 1 | 2018 | 16 | 0.140 |
Why?
|
| Consensus | 1 | 2019 | 195 | 0.140 |
Why?
|
| Anthropometry | 1 | 2018 | 102 | 0.140 |
Why?
|
| Indians, North American | 1 | 2018 | 36 | 0.140 |
Why?
|
| Adolescent Development | 1 | 2017 | 25 | 0.130 |
Why?
|
| Pregnancy | 2 | 2015 | 2642 | 0.130 |
Why?
|
| Adult | 7 | 2024 | 14205 | 0.130 |
Why?
|
| Gross Domestic Product | 1 | 2016 | 2 | 0.130 |
Why?
|
| Latin America | 1 | 2016 | 10 | 0.130 |
Why?
|
| Internet | 1 | 2019 | 262 | 0.130 |
Why?
|
| Middle Aged | 6 | 2024 | 13133 | 0.120 |
Why?
|
| Chronic Disease | 1 | 2018 | 579 | 0.120 |
Why?
|
| Africa South of the Sahara | 1 | 2015 | 6 | 0.120 |
Why?
|
| Vaccination | 1 | 2018 | 294 | 0.120 |
Why?
|
| Equipment Failure | 1 | 2015 | 63 | 0.120 |
Why?
|
| Intelligence Tests | 1 | 2015 | 39 | 0.110 |
Why?
|
| Health Surveys | 1 | 2015 | 238 | 0.110 |
Why?
|
| Educational Status | 1 | 2015 | 227 | 0.100 |
Why?
|
| Cohort Studies | 1 | 2018 | 1576 | 0.100 |
Why?
|
| Tretinoin | 1 | 2013 | 53 | 0.100 |
Why?
|
| Nevirapine | 1 | 2010 | 2 | 0.080 |
Why?
|
| Tanzania | 1 | 2010 | 6 | 0.080 |
Why?
|
| Alkynes | 1 | 2010 | 6 | 0.080 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2010 | 33 | 0.080 |
Why?
|
| Benzoxazines | 1 | 2010 | 18 | 0.080 |
Why?
|
| Cyclopropanes | 1 | 2010 | 27 | 0.080 |
Why?
|
| Models, Biological | 1 | 2013 | 735 | 0.080 |
Why?
|
| HIV-1 | 1 | 2010 | 60 | 0.080 |
Why?
|
| Incidence | 2 | 2025 | 1096 | 0.080 |
Why?
|
| RNA, Viral | 1 | 2010 | 123 | 0.080 |
Why?
|
| Aged | 3 | 2022 | 10242 | 0.080 |
Why?
|
| Recurrence | 1 | 2010 | 680 | 0.070 |
Why?
|
| Bolivia | 2 | 2018 | 3 | 0.070 |
Why?
|
| Predictive Value of Tests | 1 | 2010 | 938 | 0.070 |
Why?
|
| Severity of Illness Index | 1 | 2010 | 1045 | 0.060 |
Why?
|
| Salaries and Fringe Benefits | 1 | 2024 | 15 | 0.060 |
Why?
|
| Environmental Exposure | 1 | 2025 | 225 | 0.050 |
Why?
|
| Acoustic Impedance Tests | 1 | 2023 | 8 | 0.050 |
Why?
|
| Breast Feeding | 1 | 2025 | 201 | 0.050 |
Why?
|
| Ear, Middle | 1 | 2023 | 19 | 0.050 |
Why?
|
| Sierra Leone | 1 | 2022 | 1 | 0.050 |
Why?
|
| Uncertainty | 1 | 2022 | 45 | 0.050 |
Why?
|
| Nutrition Surveys | 1 | 2022 | 119 | 0.050 |
Why?
|
| Comparative Effectiveness Research | 1 | 2021 | 51 | 0.050 |
Why?
|
| Disease Outbreaks | 1 | 2022 | 121 | 0.040 |
Why?
|
| Organizational Objectives | 1 | 2021 | 35 | 0.040 |
Why?
|
| Lassa virus | 1 | 2020 | 1 | 0.040 |
Why?
|
| Africa, Western | 1 | 2020 | 5 | 0.040 |
Why?
|
| Infant, Newborn | 2 | 2018 | 2871 | 0.040 |
Why?
|
| Health Services Needs and Demand | 1 | 2021 | 161 | 0.040 |
Why?
|
| Community Health Workers | 1 | 2019 | 58 | 0.040 |
Why?
|
| Program Development | 1 | 2019 | 164 | 0.040 |
Why?
|
| Puberty | 1 | 2018 | 27 | 0.040 |
Why?
|
| Parturition | 1 | 2018 | 50 | 0.040 |
Why?
|
| Developed Countries | 1 | 2018 | 17 | 0.030 |
Why?
|
| Seasons | 1 | 2018 | 95 | 0.030 |
Why?
|
| Cost of Illness | 1 | 2018 | 120 | 0.030 |
Why?
|
| Disabled Persons | 1 | 2018 | 72 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2020 | 1202 | 0.030 |
Why?
|
| Animals | 1 | 2016 | 13485 | 0.010 |
Why?
|